Diagnostics News and Research RSS Feed - Diagnostics News and Research

Nutrition could be cost-effective treatment to improve health in malnourished older adults

Nutrition could be cost-effective treatment to improve health in malnourished older adults

As a majority of older adults have two or more chronic conditions, finding new ways to improve their health and decrease the cost of care is vital to helping them live healthier, longer lives. [More]
Platelet function testing in elderly patients after heart attack shows no improved outcomes

Platelet function testing in elderly patients after heart attack shows no improved outcomes

Monitoring platelet function in order to individualize antiplatelet therapy did not improve outcomes for elderly patients after a heart attack compared to a standard, unmonitored approach, results of the ANTARCTIC trial show. [More]
NEJM publishes MINDACT trial results

NEJM publishes MINDACT trial results

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces the peer-reviewed publication of the primary outcome results of the Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy (MINDACT) clinical trial in the prestigious New England Journal of Medicine (NEJM). (i, iii, iv) The publication demonstrates that 46% of breast cancer patients considered for chemotherapy, whose tumors are classified MammaPrint Low Risk, have excellent survival without chemotherapy, and can thus be candidates to avoid this toxic therapy. [More]
Scientists isolate new multicomponent virus from mosquitoes

Scientists isolate new multicomponent virus from mosquitoes

Scientists have identified a new "multicomponent" virus -- one containing different segments of genetic material in separate particles -- that can infect animals, according to research published today in the journal Cell Host & Microbe. [More]
Researchers develop new method to culture norovirus in intestinal cells

Researchers develop new method to culture norovirus in intestinal cells

Researchers have succeeded in culturing norovirus in human intestinal cells, a breakthrough that could help scientists develop novel therapeutics and vaccines against the debilitating effects of the virus. [More]
Curbing immune system infighting could make treatment more effective for pancreatic cancer

Curbing immune system infighting could make treatment more effective for pancreatic cancer

Internal conflict between cell types explains why the immune system struggles to recognize and attack pancreatic cancer. [More]
Advances in brain research since patient HM: an interview with Dr Jacopo Annese

Advances in brain research since patient HM: an interview with Dr Jacopo Annese

Jacopo Annese, President and CEO of the Institute for Brain and Society, a non-profit organization dedicated to democratizing neuroscience and making neuroscience tools and knowledge about the brain more available to the public, discusses his work on the Human Brain Library. [More]
Interpace Diagnostics introduces new AccuCEA Insights for diagnosing and treating pancreatic cancer

Interpace Diagnostics introduces new AccuCEA Insights for diagnosing and treating pancreatic cancer

Interpace Diagnostics Group, a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for better patient diagnosis and management, reported today that the Company has launched a new version of their AccuCEAâ„¢ product called "Insights" for Gastroenterologists who focus on diagnosing and treating pancreatic cancer. [More]
Portable Lab-on-a-Stick test helps in rapid detection of bacterial resistance to antibiotics

Portable Lab-on-a-Stick test helps in rapid detection of bacterial resistance to antibiotics

A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading. [More]
Scientists discover novel African types of Salmonella linked to blood poisoning and death

Scientists discover novel African types of Salmonella linked to blood poisoning and death

The first global-scale genetic study of Salmonella Enteritidis bacteria, which is a major cause of blood poisoning and death in Africa and food poisoning in the Western World, has discovered that there are in fact three separate types. [More]
New NIST Standard Reference Material helps ensure accurate measurements of HER2 breast cancer gene

New NIST Standard Reference Material helps ensure accurate measurements of HER2 breast cancer gene

A new measurement standard developed by the National Institute of Standards of Technology has been used successfully by the Frederick National Laboratory for Cancer Research to check the performance of next-generation DNA-sequencing technologies for evaluating gene variations associated with an increased risk of breast cancer. [More]
New collaborative study aims to identify mutations to improve clinical management of breast cancer

New collaborative study aims to identify mutations to improve clinical management of breast cancer

Mr. Peter Goodhand, President of The Ontario Institute for Cancer Research (OICR), today announced a new collaborative research study in partnership with Thermo Fisher Scientific and Queen's University to help bring more targeted diagnosis and treatment to breast cancer patients in the future. [More]
AMP releases new report that addresses challenges in defining clinical utility of molecular diagnostics

AMP releases new report that addresses challenges in defining clinical utility of molecular diagnostics

The Association for Molecular Pathology, the premier global, non-profit organization serving molecular diagnostic professionals, today announced a new report that addresses the challenges in defining the clinical utility of molecular diagnostics for inherited diseases and cancer. [More]
Research article outlines utilization of calixarenes in biocatalysis and cancer therapy

Research article outlines utilization of calixarenes in biocatalysis and cancer therapy

Calixarenes bear a fascinating class of macrocycles that have served broadly in molecular recognition and supramolecular chemistry. [More]
Research provides insight into how harmless nasal bacteria help protect from diseases

Research provides insight into how harmless nasal bacteria help protect from diseases

Staphylococcus aureus is a common colonizer of the human body. Although, one quarter of the U.S. population live with the bacteria and never get sick, having S. aureus present in the nostrils is a risk for infections that range in severity from mild skin to life- threatening MRSA infections. [More]
NIH researchers design new set of assays for initial screening of patients with Fragile X syndrome

NIH researchers design new set of assays for initial screening of patients with Fragile X syndrome

Fragile X syndrome, the most common heritable cause of intellectual disability and a frequent cause of autism, is characterized by abnormalities of the FMR1 gene that are difficult to analyze. [More]
Study provides detailed picture of genetics underlying type 2 diabetes

Study provides detailed picture of genetics underlying type 2 diabetes

The largest study of its kind into type 2 diabetes has produced the most detailed picture to date of the genetics underlying the condition. [More]
Study sheds new light on how medical diagnostics can be enhanced by obtaining several opinions

Study sheds new light on how medical diagnostics can be enhanced by obtaining several opinions

Methods of collective intelligence can result in considerably more accurate medical diagnoses, but only under certain conditions. [More]
Integration of multiple types of protein biomarkers improves ability to detect breast cancer

Integration of multiple types of protein biomarkers improves ability to detect breast cancer

A first-time study published in PLOS ONE shows that a combined assessment of multiple types of protein biomarkers in the blood offers an important advancement for detecting early breast cancer. [More]
Mayo Clinic launches new blood test that measures plasma ceramides to predict risk for heart disease

Mayo Clinic launches new blood test that measures plasma ceramides to predict risk for heart disease

Mayo Clinic has launched a new type of blood test that will be used to predict adverse cardiovascular events in patients with progressing coronary artery disease (CAD). [More]
Advertisement
Advertisement